Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Harbour BioMed to Announce 2022 Interim Results on August 31, 2022 2022-08-09 15:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-004 2022-08-09 12:00
BGI Ranks No. 1 among APAC and China Life Science Corporations for Seven Consecutive Years: 2022 Nature Index Annual Tables Revealed 2022-08-08 22:00
PNAS Published Preclinical Results of Harbour BioMed's Next-Generation Fully Human Heavy-chain Antibody Porustobart 2022-08-08 17:43
The world's leading brand of fashionable colored masks officially launches on Amazon on August 8th from CSD, a professional disposable medical supplies manufacturer in Taiwan 2022-08-08 13:04
ImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug Designation 2022-08-08 08:30
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy 2022-08-07 07:00
WeTrade Group Announced a Strategic Partnership with Jiqing Bio Company, to Exclusively Sell Monkeypox Test Kits and Antigen Tests 2022-08-05 21:10
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms 2022-08-05 20:45
Yiling's Lianhua Health Products Well-received: CICPE 2022-08-05 15:54
111 to Announce Second Quarter 2022 Unaudited Financial Results on August 25, 2022 - Conference Call to Follow 2022-08-05 14:26
CGBio Signing a North America Out-license Contract on "Novosis rhBMP-2," a Bone Substitute with Orthofix, USA 2022-08-04 21:00
The Debut of TIANGEN Received Passionate Feedback at AACC 2022 2022-08-04 18:30
RADIOPHARM ENTERS INTO STRATEGIC COLLABORATION WITH LANTHEUS AND ASSUMES PD-L1 LICENSING AGREEMENT FROM NANOMAB 2022-08-04 10:15
ST Pharm Presents Phase 1 Clinical Trial Results of HIV Treatment Candidate at AIDS 2022 2022-08-03 20:00
ProfoundBio Receives FDA "Study May Proceed" Letter for PRO1184, a Folate Receptor Alpha-Directed ADC with a Topoisomerase 1 Inhibitor Payload, and Welcomes Naomi Hunder, M.D., as Chief Medical Officer 2022-08-03 20:00
Kintor Pharma Announces Completion of Patient Enrollment in Phase II Clinical Trial of KX-826 for Treatment of Androgenetic Alopecia in the US 2022-08-03 19:38
Sanyou Biopharmaceuticals Closed the Series B+ Financing Round of Tens of Millions of RMB Led by Huatai Zijin 2022-08-03 08:00
GenKOre develops hypercompact base editing system 2022-08-02 22:44
Gracell Biotechnologies to Report Second Quarter 2022 Financial on Monday, August 15, 2022 2022-08-02 21:00
1 117 118 119 120 121 432